What an AMAZING past 2 days for $PDSB and other biotech names... truly happy for those who were able to catch this!
Literally up almost 50% in 2 days. 🫡❤️
Just need to watch out for 4H purple resistance, not a bad idea to lock in some gains IMO, as it seems like everyone made a lot here.
And also gotta watch for potential purple breakout next.
Show more
Biotech theme is back... 🫡📈
Really think that $PDSB is still quite early compared to $NAUT and $QSI (still like both) as it's having a brand new breakout today.
Despite the green day, IMO this is way better than buying at $1.80 2 weeks ago. 👍
Phase 2 data published in JAMA Oncology showed a 36% objective response rate in CPS ≥1 patients, versus a 19% historical benchmark.
Patrick Soon-Shiong from $IBRX is also now on the cap table... nice.
Congrats to those who rode $NAUT and $QSI with me... think our current biotech focus is trying to get more $PDSB, as other ideas are REALLY starting to run.
Show more
$PDSB first monthly gold zone breakout in 4 years... time for some popcorn? 🍿
$QSI, $NAUT, and $ARKG (biotech ETF) all continuing to look good too IMO.
Would be funny if all 3 went to $10 psychological resistance in Q4. 😂
$PDSB $QSI $NAUT
Time for $ABCL fun again if it can close above daily silver resistance today! 🔷
Would be funny.
$PDSB $QSI $NAUT
Would be funny if all 3 went to $10 psychological resistance in Q4. 😂
$PDSB $QSI $NAUT
Mean reversion for $AXTI is complete as predicted in the elder scrolls. 😀
Now let's see the reaction here at the daily gold zone... of course I'm hoping for a breach and reclaim. 🙏📈
Show more
Maybe time for a little mean reversion back to the daily gold zone for $AXTI, then let's see how it reacts there...
First pink diamond came in around $80.
Lots of AI-related tickers look like this... terrible sentiment and due for some sort of mean reversion IMO.
Show more
Biotech likes to do crazy things in Q4 of midterm years... now that all leverage has been wiped out by the October rollercoaster, it's time for blue sky soon IMO. 🫡📈
$ARKG $PDSB $QSI $NAUT
Show more
Would be funny if all 3 went to $10 psychological resistance in Q4. 😂
$PDSB $QSI $NAUT
Biotech theme is back... 🫡📈
Really think that $PDSB is still quite early compared to $NAUT and $QSI (still like both) as it's having a brand new breakout today.
Despite the green day, IMO this is way better than buying at $1.80 2 weeks ago. 👍
Phase 2 data published in JAMA Oncology showed a 36% objective response rate in CPS ≥1 patients, versus a 19% historical benchmark.
Patrick Soon-Shiong from $IBRX is also now on the cap table... nice.
Congrats to those who rode $NAUT and $QSI with me... think our current biotech focus is trying to get more $PDSB, as other ideas are REALLY starting to run.
Show more
$CIFR first (daily) blue diamond and now we're looking for a second one! 🔷
Watching neoclouds closely with Startup users... will keep updating. 🫡
$CIFR next weekly blue diamond is obviously a very good entry... will update as soon as I see anything! 🫡🔷
Biotech theme is back... 🫡📈
Really think that $PDSB is still quite early compared to $NAUT and $QSI (still like both) as it's having a brand new breakout today.
Despite the green day, IMO this is way better than buying at $1.80 2 weeks ago. 👍
Phase 2 data published in JAMA Oncology showed a 36% objective response rate in CPS ≥1 patients, versus a 19% historical benchmark.
Patrick Soon-Shiong from $IBRX is also now on the cap table... nice.
Congrats to those who rode $NAUT and $QSI with me... think our current biotech focus is trying to get more $PDSB, as other ideas are REALLY starting to run.
Show more
$QSI if you're not making money this week, don't worry... got one more idea incoming.
Biotech absolutely printing.
For those asking about $QSI, it's pretty far from silver resistance on all timeframes.
Ticker is also interesting because apparently it can read splicing errors that others can't catch in the proteome layer.
Looks like the start of a powerful wave 3.
Show more
For those asking about $QSI, it's pretty far from silver resistance on all timeframes.
Ticker is also interesting because apparently it can read splicing errors that others can't catch in the proteome layer.
Looks like the start of a powerful wave 3.
Show more
Maybe time for a little mean reversion back to the daily gold zone for $AXTI, then let's see how it reacts there...
First pink diamond came in around $80.
Lots of AI-related tickers look like this... terrible sentiment and due for some sort of mean reversion IMO.
Show more
$NAUT has hit my profit zone and if it can breach purple/silver resistance today, it's time to reveal my next target. 😊
As mentioned, might have a new ticker idea today so stay tuned... researched it with Startup users over the weekend!
Show more
If $NAUT can reclaim the weekly gold zone today (important), there's not much resistance until approx $3.30 to $3.60 on all major timeframes IMO.
Pristine triple blue (weekly). 🔷
Saw some chatter about this biotech ticker ($ARKG still very strong), but it's good to know where the levels are at!
Show more
$IREN and rest of the neocloud theme is seeing the exact same price action as the previous midterm year in 2022.
Then everything went up for 3 years.
Those who like the stock should be excited about increasingly better entries.
Watching closely with Startup users...
Will keep updating! 🔷🫡
Show more
$IREN probably isn't going to $7.52 (when I first shared it) but I think there's going to be a VERY good entry in the coming weeks.
Will share thoughts when time is right. 🫡
$CIFR $NBIS $NUAI $WULF $WYFI too.
Show more
$BTC a kind reminder we have 2 MONTHLY blue diamonds now for Bitcoin. 🔷
2014: Massive Bear Market (Buy)
2015: Relax
2016: Relax
2017: Sell and Buy Porsche
2018: Massive Bear Market (Buy)
2019: Relax
2020: Relax
2021: Sell and Buy Porsche
2022: Massive Bear Market (Buy)
2023: Relax
2024: Relax
2025: Sell and Buy Porsche
2026: Massive Bear Market (Buy)
2027: Relax
2028: Relax
2029: Sell and Buy Porsche
2030: Massive Bear Market (Buy)
Keeping it simple with Startup users.
Bullish $ASST $IBIT etc. too... 🫡
Q4 DCA stops Jan 1 and then we ride.
Show more
$GTLB there's always a bull market somewhere... some stocks don't care about what's happening to the overall market!
Up over 2X since our weekly blue diamond and probably heading higher.
We've been watching this one since August... purple resistance flipped into support. 🔷🫡
Show more
$GTLB weekly still looks intact via the Startup indicator suite... will be watching earnings in 2 days.
$RKLB I'm seeing the first daily blue diamond after our pink diamonds came in around $70... time to retest the gold zone?
Silver support (invalidation) refuses to break... seems pretty reasonable.
Show more
$ASST triple blue daily, with a perfect retest of our Startup gold zone so far!
Could chop around here as $BTC does its thing but just need to continue holding the gold for more fun...
Will keep updating.
Show more
$ASST triple blue weekly...
Not in this one currently, but covered it before and wanted to start responding to requests a lot more often. 🔷🫡
$ABCL moves VERY smoothly... I expect the next blue diamond to be pristine! 🫡
Down almost 20% since the PD.
Watching closely with Startup users.
$ABCL patiently awaiting the next blue diamond so we can have fun again! 🔷
Currently at daily gold support.
Watching closely with Startup users.
Hello my $NAUT friends... ❤️🙌
Clear the upcoming $3 resistance zone (very important so watch closely) and this enters unchartered territory.
Watching closely with Startup users.
Show more
If $NAUT can reclaim the weekly gold zone today (important), there's not much resistance until approx $3.30 to $3.60 on all major timeframes IMO.
Pristine triple blue (weekly). 🔷
Saw some chatter about this biotech ticker ($ARKG still very strong), but it's good to know where the levels are at!
Show more